CDC official: Pandemic “explosion” of antibiotic resistance not seen

  18 September 2020

Despite concerns over antimicrobial resistance flourishing during the pandemic as doctors use all their tools to help patients fight COVID-19, early indications are that their efforts may not be causing a large increase, a CDC official tells Axios.

Why it matters: AMR is a growing problem, as the misuse or overuse of antibiotics creates resistant pathogens that cause more than 2.8 million infections and 35,000 deaths annually in the U.S.

  • AMR is projected to kill up to 10 million people per year globally by 2050.

What’s happening: COVID-19 appears to present “the perfect storm” for AMR infections due to the longer length of hospital stays (averaging 8.4 days), crowding, PPE shortages, and intrusive treatments, says Arjun Srinivasan, CDC’s associate director for Healthcare Associated Infection Prevention Programs.

Further reading: Axios
Author(s): Eileen Drage O'Reilly
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





EADA 2023

Emerging Antimicrobials and Diagnostics in AMR 2023

International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands
16/17 November

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!